• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)

    10/5/23 12:01:56 PM ET
    $MKD
    Business Services
    Consumer Discretionary
    Get the next $MKD alert in real time by email
    SC 13G/A 1 doc1.htm NONE Schedule 13G


     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13G
     
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 02)*
     
    Molecular Data Inc. 

    (Name of Issuer)
     
    Class A ordinary shares, par value US$0.00005 per share

    (Title of Class of Securities)
     
    60852L106

    (CUSIP Number)
     
    Calendar Year 2023

    (Date of Event Which Requires Filing of this Statement)
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
         o  Rule 13d-1(b)
     
         x  Rule 13d-1(c)
     
         o  Rule 13d-1(d)
     
    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
     
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     


     
     

     
     
    CUSIP No.  60852L106      
     
          
    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     Streeterville Capital LLC
    85-2954598
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

     (a)   o
     (b)   o
       
    3 SEC USE ONLY
      
      
       
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
      
     Utah
        
    NUMBER OF SHARES BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER
      
     35,900,305
       
    6 SHARED VOTING POWER
      
     
       
    7 SOLE DISPOSITIVE POWER
      
     35,900,305
       
    8 SHARED DISPOSITIVE POWER
      
     
       
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     35,900,305
       
    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
     o
       
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     9.99*%
       
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     OO
     

    FOOTNOTES
      
     *Reporting Person Streeterville Capital LLC (“Streeterville”) has rights, under a Securities Purchase Agreement and Convertible Debenture, to own an aggregate number of shares of the Issuer’s Class A ordinary shares or ADSs which, except for a contractual cap on the amount of outstanding shares that Streeterville may own, would exceed such cap. Streeterville's current ownership cap is 9.99%. Thus, the number of shares of the Issuer's Class A ordinary shares beneficially owned by Streeterville as of the date of this filing was 35,900,305 shares, which is 9.99% of the 359,362,418 Class A ordinary shares outstanding on April 7, 2021 (as reported in that certain Convertible Debenture issued by Issuer on April 7, 2021 in favor of Streeterville).
     
     

     
     
    CUSIP No.  60852L106      
     
          
    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     Streeterville Management LLC
    85-3223919
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

     (a)   o
     (b)   o
       
    3 SEC USE ONLY
      
      
       
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
      
     Utah
        
    NUMBER OF SHARES BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER
      
     35,900,305
       
    6 SHARED VOTING POWER
      
     
       
    7 SOLE DISPOSITIVE POWER
      
     35,900,305
       
    8 SHARED DISPOSITIVE POWER
      
     
       
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     35,900,305
       
    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
     o
       
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     9.99*%
       
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     OO
     

    FOOTNOTES
      
     *Reporting person Streeterville Management LLC is the Manager of reporting person Streeterville. Streeterville has rights, under a Securities Purchase Agreement and Convertible Debenture, to own an aggregate number of shares of the Issuer’s Class A ordinary shares or ADSs which, except for a contractual cap on the amount of outstanding shares that Streeterville may own, would exceed such cap. Streeterville's current ownership cap is 9.99%. Thus, the number of shares of the Issuer's Class A ordinary shares beneficially owned by Streeterville as of the date of this filing was 35,900,305 shares, which is 9.99% of the 359,362,418 Class A ordinary shares outstanding on April 7, 2021 (as reported in that certain Convertible Debenture issued by Issuer on April 7, 2021 in favor of Streeterville).
     
     

     
     
    CUSIP No.  60852L106      
     
          
    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     John M. Fife
       
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

     (a)   o
     (b)   o
       
    3 SEC USE ONLY
      
      
       
    4 CITIZENSHIP OR PLACE OF ORGANIZATION
      
     United States of America
        
    NUMBER OF SHARES BENEFICIALLY  OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER
      
     35,900,305
       
    6 SHARED VOTING POWER
      
     
       
    7 SOLE DISPOSITIVE POWER
      
     35,900,305
       
    8 SHARED DISPOSITIVE POWER
      
     
       
    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
      
     35,900,305
       
    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
      
     o
       
    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      
     9.99*%
       
    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
      
     IN
     

    FOOTNOTES
      
     *John M. Fife is the sole member of Streeterville Management LLC, which is the Manager of reporting person Streeterville. Streeterville has rights, under a Securities Purchase Agreement and Convertible Debenture, to own an aggregate number of shares of the Issuer’s Class A ordinary shares or ADSs which, except for a contractual cap on the amount of outstanding shares that Streeterville may own, would exceed such cap. Streeterville's current ownership cap is 9.99%. Thus, the number of shares of the Issuer's Class A ordinary shares beneficially owned by Streeterville as of the date of this filing was 35,900,305 shares, which is 9.99% of the 359,362,418 Class A ordinary shares outstanding on April 7, 2021 (as reported in that certain Convertible Debenture issued by Issuer on April 7, 2021 in favor of Streeterville).
     
     

     
     
    Item 1.

     
    (a)
    Name of Issuer
     
     
    Molecular Data Inc.

     
    (b)
    Address of Issuer’s Principal Executive Offices
     
     
    11/F, Building 15, 2177 Shenkun Road
    Minhang District, Shanghai 201106
    People’s Republic of China

    Item 2.

     
    (a)
    Name of Person Filing
     
     
    This report is filed by Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife with respect to the shares of Class A Ordinary Shares of the Issuer that are directly beneficially owned by Streeterville Capital LLC and indirectly beneficially owned by the other reporting and filing persons.

     
    (b)
    Address of Principal Business Office or, if none, Residence
     
     
    303 E Wacker Drive, Suite 1040
    Chicago, IL 60601

     
    (c)
    Citizenship
     
     
    Streeterville Capital LLC is a Utah limited liability company.
    Streeterville Management LLC is a Utah limited liability company.
    John M. Fife is a United States citizen.

     
    (d)
    Title of Class of Securities
     
     
    Class A Ordinary Shares, $0.0005 par value per share

     
    (e)
    CUSIP Number
     
     
    60852L106

    CUSIP 60852L106 has been assigned to the American Depositary Shares (“ADSs”) of the issuer, which are quoted on The Nasdaq Stock Market LLC under the symbol “MKD”. Each ADS represents three Class A ordinary shares of the issuer.

     
    Item 3.
    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     
    (a)
    o
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

     
    (b)
    o
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

     
    (c)
    o
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

     
    (d)
    o
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).

     
    (e)
    o
    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

     
    (f)
    o
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

     
    (g)
    o
    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     
    (h)
    o
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     
    (i)
    o
    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     
    (j)
    o
    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J).

     
    (k)
    o
    A group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

     
     
     

     
     
    Item 4.
    Ownership.
     
    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     
    (a)
    Amount beneficially owned: 35,900,305

     
    (b)
    Percent of class: 9.99%

     
    (c)
    Number of shares as to which the person has:

     
    (i)
    Sole power to vote or to direct the vote: 35,900,305

     
    (ii)
    Shared power to vote or to direct the vote: 0

     
    (iii)
    Sole power to dispose or to direct the disposition of: 35,900,305

     
    (iv)
    Shared power to dispose or to direct the disposition of: 0

    Item 5.
    Ownership of Five Percent or Less of a Class
     
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o .
     
    N/A
     
    Item 6.
    Ownership of More than Five Percent on Behalf of Another Person.
     
    N/A
     
    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
     
    N/A
     
    Item 8.
    Identification and Classification of Members of the Group
     
    N/A
     
    Item 9.
    Notice of Dissolution of Group
     
    N/A
     
     
     

     
     
     
    Item 10.
    Certification
      
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
     
     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
     
     Streeterville Capital LLC
     
        
    Date: October 05, 2023
    By:
    /s/  John M. Fife 
       Name: John M. Fife 
       Title:  President 
        
     
     
     
     Streeterville Management LLC
     
        
    Date: October 05, 2023
    By:
    /s/  John M. Fife 
       Name: John M. Fife 
       Title:  Member 
        
     
     
     
     John M. Fife
     
        
    Date: October 05, 2023
    By:
    /s/  John M. Fife 
       Name: John M. Fife 
       
        
     
    Footnotes:

    Attention:
    Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
     
     


    Get the next $MKD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MKD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MKD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Molecular Data Inc.

      SC 13G - Molecular Data Inc. (0001758736) (Subject)

      2/5/24 9:48:58 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)

      SC 13G/A - Molecular Data Inc. (0001758736) (Subject)

      10/5/23 12:01:56 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Molecular Data Inc. (Amendment)

      SC 13G/A - Molecular Data Inc. (0001758736) (Subject)

      2/9/23 9:25:36 PM ET
      $MKD
      Business Services
      Consumer Discretionary

    $MKD
    SEC Filings

    See more
    • SEC Form 25-NSE filed by Molecular Data Inc.

      25-NSE - Molecular Data Inc. (0001758736) (Subject)

      10/27/22 9:15:54 AM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form 6-K filed by Molecular Data Inc.

      6-K - Molecular Data Inc. (0001758736) (Filer)

      5/27/22 5:00:13 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • SEC Form 6-K filed by Molecular Data Inc.

      6-K - Molecular Data Inc. (0001758736) (Filer)

      5/20/22 11:58:23 AM ET
      $MKD
      Business Services
      Consumer Discretionary

    $MKD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Molecular Data Inc. Receives NASDAQ Notification

      SHANGHAI, June 24, 2022  /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ:MKD), a technology-driven platform in China, announced that it had received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that to date, it has not regained compliance with the Rule 5250(c)(1). Since the Company is already before a Hearings Panel for its failure to comply with the $1.00 minimum bid price requirement set forth in Listing Rule 5550(a)(2),pursuant to Listing Rule 5810(d)(2), rather than submit a compliance plan for Staff's review, the Company is to address the matter before the Hearings Panel. About Molecular Data, Inc. Molecular Data Inc. is a

      6/24/22 5:15:00 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • Molecular Data Inc. Receives NASDAQ Notification Regarding Minimum Bid Requirements

      SHANGHAI, May 27, 2022 /PRNewswire/ -- Molecular Data, Inc. ("Molecular Data" or the "Company") (NASDAQ:MKD), a technology-driven platform in China, announced today that on May 25, 2021, it had received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that its minimum closing bid price per share for its ordinary shares had fallen below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). On November 29, 2021, the Company was provided with an additional 180 calendar day compliance period, or until May 23, 2022, to demonstrate compliance. On May 24, 2022, th

      5/27/22 10:53:00 PM ET
      $MKD
      Business Services
      Consumer Discretionary
    • Molecular Data Inc. Announces ADS Ratio Change

      SHANGHAI, May 20, 2022 /PRNewswire/ -- Molecular Data Inc. (NASDAQ:MKD) (the "Company") announced today a ratio change on its American Depositary Shares ("ADS") from the current one (1) ADS representing three (3) Class A ordinary shares to the new ratio of one (1) ADS representing forty-five (45) Class A ordinary shares (the "Ratio Change"). The effective date of the Ratio Change is expected to be May 23, 2022. Each ADS holder of record at the close of business on the date when the change in ADS ratio is effective will be required to surrender and exchange every fifteen (15) existing ADSs then held for one (1) new ADS. JPMorgan Chase Bank, N.A., as the depositary bank for the Company's ADS p

      5/20/22 12:14:00 PM ET
      $MKD
      Business Services
      Consumer Discretionary

    $MKD
    Leadership Updates

    Live Leadership Updates

    See more
    • WATERDROP ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR

      BEIJING, May 2, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE:WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced the appointment of Mr. Ning Zhu as a new independent director to its board of directors (the "Board") and the resignation of Mr. Peng Shen as a member of the audit committee of the Board, both effective May 2, 2022. Mr. Zhu will also serve as a member of the audit committee of the Board. After the change, the Board will consist of nine members, three of whom are independent directors, and the audit committee will consist solely of independent directors. Mr. Ning Zhu has b

      5/2/22 8:00:00 AM ET
      $MKD
      $WDH
      Business Services
      Consumer Discretionary
      Specialty Insurers
      Finance
    • Molecular Data Inc. Announces Changes of Chief Financial Officer

      SHANGHAI, China, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Molecular Data Inc. (“Molecular Data” or the “Company”) (Nasdaq: MKD), a leading technology-driven platform in China’s chemical industry, today announced that the Company has appointed Mr. Steven Foo as the new chief financial officer, effective December 1, 2020. Mr. Zhaohong Li has tendered his resignation as chief financial officer, for personal reasons. “We greatly appreciate the contributions that Zhaohong has made during his tenure with the Company, leading our IPO, and building a public company finance team. We respect Zhaohong’s decision and wish him the very best in his future pursuits,” said Dr. Dongliang Chang, Founder and Chair

      12/2/20 7:00:00 AM ET
      $MKD
      Business Services
      Consumer Discretionary